المؤلفون: Gostev AA; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation. Electronic address: dr.gostev@gmail.com., Valiev E; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation., Zeidlits GA; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation., Shmidt EA; Scientific and Research Institute of Complex Cardiovascular Problems, Kemerovo, Russian Federation., Osipova OS; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation., Cheban AV; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation., Saaya SB; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation., Barbarash OL; Scientific and Research Institute of Complex Cardiovascular Problems, Kemerovo, Russian Federation., Karpenko AA; Meshalkin National Medical Research Center, Novosibirsk, Russian Federation.

المصدر: Journal of vascular surgery. Venous and lymphatic disorders [J Vasc Surg Venous Lymphat Disord] 2024 Jul; Vol. 12 (4), pp. 101848. Date of Electronic Publication: 2024 Feb 10.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Comparative Study

بيانات الدورية: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101607771 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-3348 (Electronic) NLM ISO Abbreviation: J Vasc Surg Venous Lymphat Disord Subsets: MEDLINE

مواضيع طبية MeSH: Dabigatran*/adverse effects , Dabigatran*/administration & dosage , Warfarin*/adverse effects , Warfarin*/administration & dosage , Pulmonary Embolism*/prevention & control , Pulmonary Embolism*/drug therapy , Pulmonary Embolism*/etiology , Anticoagulants*/adverse effects , Anticoagulants*/administration & dosage , Thrombolytic Therapy*/adverse effects , Antithrombins*/adverse effects , Antithrombins*/administration & dosage, Humans ; Male ; Female ; Middle Aged ; Aged ; Treatment Outcome ; Prospective Studies ; Acute Disease ; Time Factors ; Recurrence ; Adult ; beta-Alanine/analogs & derivatives ; beta-Alanine/adverse effects ; beta-Alanine/administration & dosage ; Risk Factors ; Hemorrhage/chemically induced ; International Normalized Ratio

المؤلفون: Balogh G; Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary., Bereczky Z; Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.

المصدر: Biomolecules [Biomolecules] 2024 Jun 04; Vol. 14 (6). Date of Electronic Publication: 2024 Jun 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101596414 Publication Model: Electronic Cited Medium: Internet ISSN: 2218-273X (Electronic) Linking ISSN: 2218273X NLM ISO Abbreviation: Biomolecules Subsets: MEDLINE

مواضيع طبية MeSH: Heparin*/metabolism , Heparin*/chemistry , Molecular Dynamics Simulation* , Antithrombins*/chemistry , Antithrombins*/metabolism , Mutation*, Binding Sites ; Humans ; Protein Binding ; Oligosaccharides/chemistry ; Oligosaccharides/metabolism

المؤلفون: Sukumaran M; Clinical Fellow, Cerebrovascular and Endovascular Neurosurgery, Department of Neurosurgery, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02215, United States. Electronic address: msukumaran1@bwh.harvard.edu., Cantrell DR; Departments of Radiology and Neurology, Northwestern Medicine, United States., D'Agostino C; Department of Pharmacy, Northwestern Medicine, United States., Jahromi BS; Departments of Neurological Surgery, Neurology, and Radiology, Northwestern Medicine, United States., Ansari SA; Departments of Neurological Surgery, Neurology, and Radiology, Northwestern Medicine, United States., Potts MB; Departments of Neurological Surgery, Neurology, and Radiology, Northwestern Medicine, United States.

المصدر: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2024 Jun; Vol. 33 (6), pp. 107310. Date of Electronic Publication: 2024 Apr 17.

نوع المنشور: Journal Article; Case Reports; Review

بيانات الدورية: Publisher: Saunders Country of Publication: United States NLM ID: 9111633 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8511 (Electronic) Linking ISSN: 10523057 NLM ISO Abbreviation: J Stroke Cerebrovasc Dis Subsets: MEDLINE

مواضيع طبية MeSH: Anticoagulants*/adverse effects , Antithrombins*/adverse effects , Antithrombins*/therapeutic use , Heparin*/adverse effects , Hirudins* , Peptide Fragments*/therapeutic use , Peptide Fragments*/adverse effects , Recombinant Proteins*/adverse effects , Recombinant Proteins*/therapeutic use , Recombinant Proteins*/administration & dosage , Thrombocytopenia*/chemically induced , Thrombocytopenia*/diagnosis , Thrombocytopenia*/drug therapy, Humans ; Male ; Middle Aged ; Aneurysm, False/surgery ; Aneurysm, False/drug therapy ; Aneurysm, Ruptured/surgery ; Aneurysm, Ruptured/diagnostic imaging ; Drug Substitution ; Endovascular Procedures/adverse effects ; Intracranial Aneurysm/surgery ; Intracranial Aneurysm/drug therapy ; Treatment Outcome

المؤلفون: Rajab F; King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan., Mujahid A; King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan., Naseer B; King Edward Medical University, Neela gumbad, Anarkali, Lahore, Pakistan.

المصدر: European heart journal. Cardiovascular pharmacotherapy [Eur Heart J Cardiovasc Pharmacother] 2024 May 04; Vol. 10 (3), pp. 263-264.

نوع المنشور: Letter; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101669491 Publication Model: Print Cited Medium: Internet ISSN: 2055-6845 (Electronic) NLM ISO Abbreviation: Eur Heart J Cardiovasc Pharmacother Subsets: MEDLINE

مواضيع طبية MeSH: Hirudins*/adverse effects , Hirudins*/administration & dosage , Percutaneous Coronary Intervention*/adverse effects , Percutaneous Coronary Intervention*/mortality , Diabetes Mellitus, Type 2*/drug therapy , Diabetes Mellitus, Type 2*/diagnosis , Diabetes Mellitus, Type 2*/blood , Heparin*/adverse effects , Heparin*/therapeutic use , Heparin*/administration & dosage , Peptide Fragments*/therapeutic use , Peptide Fragments*/adverse effects , Antithrombins*/adverse effects , Antithrombins*/therapeutic use , Antithrombins*/administration & dosage , Recombinant Proteins*/therapeutic use , Recombinant Proteins*/adverse effects , Recombinant Proteins*/administration & dosage, Humans ; Treatment Outcome ; Anticoagulants/adverse effects ; Anticoagulants/therapeutic use ; Anticoagulants/administration & dosage ; Coronary Artery Disease/mortality ; Coronary Artery Disease/therapy ; Coronary Artery Disease/diagnosis

المؤلفون: Nakajima Y; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan; Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Japan. Electronic address: nakajima-yamanashi@naramed-u.ac.jp., Ogiwara K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan., Inaba K; Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama, Japan., Kitazawa T; Research Division, Chugai Pharmaceutical Co., Ltd., Yokohama, Japan., Nogami K; Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.

المصدر: Thrombosis research [Thromb Res] 2024 May; Vol. 237, pp. 14-17. Date of Electronic Publication: 2024 Mar 21.

نوع المنشور: Letter

بيانات الدورية: Publisher: Pergamon Press Country of Publication: United States NLM ID: 0326377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-2472 (Electronic) Linking ISSN: 00493848 NLM ISO Abbreviation: Thromb Res Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Bispecific*/pharmacology , Antibodies, Bispecific*/therapeutic use , Antibodies, Monoclonal, Humanized*/therapeutic use , Antibodies, Monoclonal, Humanized*/pharmacology , Blood Coagulation*/drug effects , Anticoagulants*/pharmacology , Anticoagulants*/therapeutic use , Antithrombins*/pharmacology , Antithrombins*/therapeutic use, Humans

المؤلفون: Mushahid H; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Shah SA; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Farhan SH; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Shuja MH; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Balasingam K; Edinburgh School of Medicine, University of Edinburgh, Edinburgh, UK., Siddiqui AA; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Hameed I; Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan., Akram K; Orlando Health Heart and Vascular Institute, Orlando, FL, USA., Mushahid S; Department of Medicine, The Dudley Group NHS Foundation Trust, Dudley, UK. Shayan.mushahid@nhs.net., Usman MS; Department of Internal Medicine, University of Texas Southwestern Medical Center, Texas, Dallas, USA.

المصدر: American journal of cardiovascular drugs : drugs, devices, and other interventions [Am J Cardiovasc Drugs] 2024 May; Vol. 24 (3), pp. 385-398. Date of Electronic Publication: 2024 Apr 29.

نوع المنشور: Systematic Review; Journal Article; Meta-Analysis

بيانات الدورية: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 100967755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-187X (Electronic) Linking ISSN: 11753277 NLM ISO Abbreviation: Am J Cardiovasc Drugs Subsets: MEDLINE

مواضيع طبية MeSH: Hirudins*/adverse effects , Hirudins*/administration & dosage , ST Elevation Myocardial Infarction*/drug therapy , ST Elevation Myocardial Infarction*/therapy , Peptide Fragments*/therapeutic use , Peptide Fragments*/adverse effects , Percutaneous Coronary Intervention*/methods , Percutaneous Coronary Intervention*/adverse effects , Recombinant Proteins*/therapeutic use , Recombinant Proteins*/adverse effects , Recombinant Proteins*/administration & dosage , Platelet Glycoprotein GPIIb-IIIa Complex*/antagonists & inhibitors , Heparin*/adverse effects , Heparin*/therapeutic use , Heparin*/administration & dosage , Antithrombins*/therapeutic use , Antithrombins*/adverse effects, Humans ; Hemorrhage/chemically induced ; Platelet Aggregation Inhibitors/therapeutic use ; Platelet Aggregation Inhibitors/adverse effects ; Randomized Controlled Trials as Topic

المؤلفون: Mansour A; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, Rennes, France; University of Rennes, National Institute of Health and Medical Research, Center of Clinical Investigation, Research Institute for Environmental and Occupational Health, University Hospital Federation Survival Optimization in Organ Transplantation, Univ Rennes, Rennes, France., Berahou M; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, Rennes, France., Odot J; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, Rennes, France., Pontis A; Department of Hematology, Pontchaillou, University Hospital of Rennes, Rennes, France; University of Rennes, National Institute of Health and Medical Research, Center of Clinical Investigation, Research Institute for Environmental and Occupational Health, University Hospital Federation Survival Optimization in Organ Transplantation, Univ Rennes, Rennes, France., Parasido A; Department of Thoracic and Cardiovascular Surgery, Pontchaillou, University Hospital of Rennes, Rennes, France., Reizine F; Department of Medical Intensive Care, University Hospital of Rennes, Rennes, France., Launey Y; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, Rennes, France., Garlantézec R; Department of Epidemiology and Public Health, Pontchaillou, University Hospital of Rennes, Rennes, France; University of Rennes, National Institute of Health and Medical Research, Center of Clinical Investigation, Research Institute for Environmental and Occupational Health, University Hospital Federation Survival Optimization in Organ Transplantation, Univ Rennes, Rennes, France., Flecher E; Department of Thoracic and Cardiovascular Surgery, Pontchaillou, University Hospital of Rennes, University of Rennes, Signal and Image Treatment Laboratory, National Institute of Health and Medical Research U1099, Rennes, France., Lecompte T; Department of Hematology, Pontchaillou, University Hospital of Rennes, Rennes, France., Nesseler N; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, Rennes, France; University of Rennes, National Institute of Health and Medical Research, Center of Clinical Investigation, Nutrition, Metabolism, Cancer Mixed Research Unit, University Hospital Federation Survival Optimization in Organ Transplantation, Univ Rennes, Rennes, France., Gouin-Thibault I; Department of Hematology, Pontchaillou, University Hospital of Rennes, Rennes, France; University of Rennes, National Institute of Health and Medical Research, Research Institute for Environmental and Occupational Health, Rennes, France.

المصدر: Anesthesiology [Anesthesiology] 2024 Jun 01; Vol. 140 (6), pp. 1153-1164.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 1300217 Publication Model: Print Cited Medium: Internet ISSN: 1528-1175 (Electronic) Linking ISSN: 00033022 NLM ISO Abbreviation: Anesthesiology Subsets: MEDLINE

مواضيع طبية MeSH: Extracorporeal Membrane Oxygenation*/methods , Heparin*/administration & dosage , Heparin*/pharmacology , Antithrombins*/blood , Anticoagulants*/administration & dosage , Anticoagulants*/pharmacology, Humans ; Prospective Studies ; Male ; Female ; Middle Aged ; Cohort Studies ; Adult ; Aged

المؤلفون: Mishima Y; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Butt AL; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Vandyck KB; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Levy JH; Duke University Medical Center, Department of Anesthesiology, Critical Care, and Surgery (Cardiothoracic), Durham, NC, USA., Stewart KE; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA; Department of Surgery, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA., Tanaka KA; Department of Anesthesiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. Electronic address: kenichi-tanaka@ouhsc.edu.

المصدر: British journal of anaesthesia [Br J Anaesth] 2024 Jun; Vol. 132 (6), pp. 1204-1210. Date of Electronic Publication: 2024 Apr 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: England NLM ID: 0372541 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-6771 (Electronic) Linking ISSN: 00070912 NLM ISO Abbreviation: Br J Anaesth Subsets: MEDLINE

مواضيع طبية MeSH: Antithrombins*/pharmacology , Drug Resistance*/drug effects , Factor Xa*/metabolism , Factor Xa Inhibitors*/pharmacology , Heparin*/pharmacology, Humans ; Anticoagulants/pharmacology ; Cardiopulmonary Bypass

المؤلفون: Iwafuchi Y; Department of Internal Medicine, Koseiren Sanjo General Hospital, Japan., Ito Y; Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan., Imai N; Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan., Oyama Y; Department of Internal Medicine, Koseiren Sanjo General Hospital, Japan., Narita I; Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan.

المصدر: Internal medicine (Tokyo, Japan) [Intern Med] 2024 Jun 01; Vol. 63 (11), pp. 1615-1621. Date of Electronic Publication: 2023 Oct 20.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

مواضيع طبية MeSH: Dabigatran*/adverse effects , Glomerulonephritis, IGA*/complications , Glomerulonephritis, IGA*/diagnosis , Nephritis, Interstitial*/chemically induced , Nephritis, Interstitial*/diagnosis , Antithrombins*/adverse effects, Humans ; Female ; Aged ; Prednisolone/therapeutic use ; Prednisolone/adverse effects ; Kidney/pathology ; Kidney/drug effects

المؤلفون: Kodaka M; Department of Anesthesiology and Intensive Care, Tokyo Women's Medical University Medical Center Adachi, Adachi-ku, Tokyo, Japan., Ichikawa J; Department of Anesthesiology and Intensive Care, Tokyo Women's Medical University Medical Center Adachi, Adachi-ku, Tokyo, Japan., Komori M; Department of Anesthesiology and Intensive Care, Tokyo Women's Medical University Medical Center Adachi, Adachi-ku, Tokyo, Japan.

المصدر: Perfusion [Perfusion] 2024 May; Vol. 39 (4), pp. 816-822. Date of Electronic Publication: 2023 Mar 06.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 8700166 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-111X (Electronic) Linking ISSN: 02676591 NLM ISO Abbreviation: Perfusion Subsets: MEDLINE

مواضيع طبية MeSH: Cardiopulmonary Bypass*/methods , Cardiopulmonary Bypass*/adverse effects , Thrombelastography*/methods , Fibrinogen*/analysis , Antithrombins*/blood , Circulatory Arrest, Deep Hypothermia Induced*/methods, Humans ; Female ; Male ; Middle Aged ; Platelet Count ; Aged